Texas Tech Health Sciences Center research targets medications for those with depression

(Texas Tech University Health Sciences Center) Researchers from Texas Tech University Health Sciences Center (TTUHSC) have discovered the FDA approved drug bupropion (Wellbutrin, Zyban) blocks the function of the serotonin type 3A receptors (5-HT3ARs) and further characterized bupropion's pharmacological effects at these receptors.